Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Clearside Biomedical Inc. (CLSD)

2.66   -0.06 (-2.21%) 02-21 16:00
Open: 2.72 Pre. Close: 2.72
High: 2.73 Low: 2.56
Volume: 249,383 Market Cap: 118M
Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.731 - 2.75 2.75 - 2.765
Low: 2.526 - 2.543 2.543 - 2.558
Close: 2.634 - 2.663 2.663 - 2.687

Technical analysis

as of: 2020-02-21 4:28:48 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.03     One year: 4.82
Support: Support1: 2.34    Support2: 1.95
Resistance: Resistance1: 3.45    Resistance2: 4.13
Pivot: 2.97
Moving Average: MA(5): 2.66     MA(20): 3.03
MA(100): 1.87     MA(250): 1.43
MACD: MACD(12,26):     Signal(9): 0.09
Stochastic oscillator: %K(14,3): 20.60     %D(3): 18.24
RSI: RSI(14): 46.18
52-week: High: 4.13  Low: 0.56  Change(%): 72.7
Average Vol(K): 3-Month: 135043  10-Days: 68028

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CLSD has closed above bottom band by 26.0%. Bollinger Bands are 36.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 02 Jan 2020 17:14:48 +0000
Thursday Sector Laggards: Agriculture & Farm Products, Drugs

Tue, 17 Dec 2019 06:59:20 +0000
Top Gainers: CLSD Making A Second Try, RLMD Abuzz, Busy Year Ahead For BTAI

Thu, 22 Aug 2019 13:10:05 +0000
Health Care Sector Update for 08/22/2019: CLSD, RTRX, ADMA, JNJ, PFE, ABT, MRK, AMGN

Thu, 22 Aug 2019 17:44:35 +0000
Health Care Sector Update for 08/22/2019: JNJ, CLSD, NTRA, RTRX, GMAB, ADMA, PFE, ABT, MRK, AMGN

Wed, 14 Mar 2018 07:14:36 +0000
5 ‘Strong Buy’ Biotechs That Can Double in 2018

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 44.41
Shares Float (M) 27.44
% Held by Insiders 9.34
% Held by Institutions 36.62
Shares Short (K) 711
Shares Short P. Month (K)

Stock Financials

EPS -1.386
Book Value (p.s.) 0.240
PEG Ratio
Profit Margin
Operating Margin -19740.61
Return on Assets (ttm) -67.6
Return on Equity (ttm) -183.2
Qtrly Rev. Growth
Gross Profit (p.s.) 0.001
Sales Per Share
EBITDA (p.s.) -1.155
Qtrly Earnings Growth
Operating Cash Flow (M) -53.02
Levered Free Cash Flow (M) -36.71

Stock Valuations

P/E -1.92
P/E Growth Ratio -0.02
P/BV 11.08
P/S 266.00
P/CF -2.23

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.